AstraZeneca | AZN - 债务



金融业
股票价格
USD
资产
USD 115.83B
现金及等价物
USD 4.89B
销售成本
USD 2.52B
流动资产
USD 27.97B
流动负债
USD 31.55B
债务
USD 32.24B
股息收益率
USD 1.75
EBIT
USD 3.16B
EBITDA
USD 5.16B
员工
USD 89.9K
EPS每股收益
USD 2.63
股本和储备
USD 50.3B
销售毛利
USD 12.86B
债务利息支出
USD 340M
利息收入
USD 80M
贷款资金
USD 26.01B
市值
USD 183.93B
净收入
USD 2.51B
营业费用
USD 12.22B
营业利润
USD 3.16B
普通股股本
USD 1.55B
PE价格收益
25.34
税前利润
USD 4.81B
销售收入
USD 15.38B
销售和管理费用
USD 5.8B
股票
USD 6.93B
贸易债权人
USD 22.89B
应收帐款人
USD 18.86B


债务 更改 日
AbbVie USD 72.86B 5.36B 2026-03
Alcon AG USD 5.25B 4.74B 2026-03
Almirall EUR 342.86M 61.94M 2025-12
Amgen USD 57.32B 2.72B 2026-03
argenx SE USD 47.16M 4.01M 2025-12
AstraZeneca USD 32.24B 1.68B 2026-06
Autolus Therapeutics Ltd USD 253.44M 8.84M 2025-03
Bayer EUR 36.45B 2.93B 2025-12
Biogen USD 8.09B 1.53B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Fresenius EUR 11.9B 28M 2026-03
Fresenius Medical Care EUR 10.96B 66.06M 2026-06
Genmab DKK 5.35B 5.2B 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
GRIFOLS EUR 8.52B 1.15B 2026-06
Haleon GBP 8.58B 130M 2025-12
Hikma Pharmaceutical USD 1.6B 46M 2025-12
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Lonza CHF 4.71B 915M 2024-12
Merck EUR 12.04B 86M 2026-03
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Orion EUR 330.3M 24.9M 2026-03
Pfizer USD 63.19B 536M 2026-06
Philips EUR 7.47B 632M 2026-06
Recordati EUR 2.31B 57.06M 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
UCB EUR 3.03B 12M 2024-12